|
ZNF491 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.1555004709769E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47180045928508E-10 |
| Normal-vs-Stage2 |
1.429840E-01 |
| Normal-vs-Stage3 |
6.73599998002317E-09 |
| Normal-vs-Stage4 |
4.5941028758989E-11 |
| Stage1-vs-Stage2 |
7.515800E-03 |
| Stage1-vs-Stage3 |
4.207600E-01 |
| Stage1-vs-Stage4 |
3.882100E-02 |
| Stage2-vs-Stage3 |
3.976000E-03 |
| Stage2-vs-Stage4 |
2.998200E-04 |
| Stage3-vs-Stage4 |
2.277400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.22253335127698E-12 |
| Normal-vs-AfricanAmerican |
6.403200E-03 |
| Normal-vs-Asian |
7.88770000000882E-05 |
| Caucasian-vs-AfricanAmerican |
5.359200E-01 |
| Caucasian-vs-Asian |
4.845500E-02 |
| AfricanAmerican-vs-Asian |
6.640000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.71240000000195E-05 |
| Normal-vs-Female |
2.54518628395317E-12 |
| Male-vs-Female |
9.543900E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.3910994578481E-10 |
| Normal-vs-Age(41-60Yrs) |
7.13500036830794E-10 |
| Normal-vs-Age(61-80Yrs) |
8.23880000000443E-05 |
| Normal-vs-Age(81-100Yrs) |
6.764600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.965400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.355210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.018800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.596980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.942800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.717000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.35619999955361E-07 |
| Classical-VS-Follicular |
3.67140000000488E-05 |
| Classical-VS-Other |
7.204800E-01 |
| Classical-VS-Normal |
6.91602330959995E-12 |
| Tall-VS-Follicular |
1.31540334180613E-11 |
| Tall-VS-Other |
9.624200E-02 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
2.831600E-01 |
| Follicular-VS-Normal |
5.476000E-02 |
| Other-VS-Normal |
1.735870E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29599999998398E-06 |
| Normal-vs-N1 |
1.25370003267733E-09 |
| N0-vs-N1 |
1.062020E-02 |
|
|
